An update on optic neuritis

J Neurol. 2023 Oct;270(10):5113-5126. doi: 10.1007/s00415-023-11920-x. Epub 2023 Aug 5.

Abstract

Optic neuritis (ON) is the most common cause of subacute optic neuropathy in young adults. Although most cases of optic neuritis (ON) are classified as typical, meaning idiopathic or associated with multiple sclerosis, there is a growing understanding of atypical forms of optic neuritis such as antibody mediated aquaporin-4 (AQP4)-IgG neuromyelitis optica spectrum disorder (NMOSD) and the recently described entity, myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD). Differentiating typical ON from atypical ON is important because they have different prognoses and treatments. Findings of atypical ON, including severe vision loss with poor recovery with steroids or steroid dependence, prominent optic disc edema, bilateral vision loss, and childhood or late adult onset, should prompt serologic testing for AQP4-IgG and MOG-IgG. Although the traditional division of typical and atypical ON can be helpful, it should be noted that there can be severe presentations of otherwise typical ON and mild presentations of atypical ON that blur these traditional lines. Rare causes of autoimmune optic neuropathies, such as glial fibrillary acidic protein (GFAP) and collapsin response-mediator protein 5 (CRMP5) autoimmunity also should be considered in patients with bilateral painless optic neuropathy associated with optic disc edema, especially if there are other accompanying suggestive neurologic symptoms/signs. Typical ON usually recovers well without treatment, though recovery may be expedited by steroids. Atypical ON is usually treated with intravenous steroids, and some forms, such as NMOSD, often require plasma exchange for acute attacks and long-term immunosuppressive therapy to prevent relapses. Since treatment is tailored to the cause of the ON, elucidating the etiology of the ON is of the utmost importance.

Keywords: Chronic relapsing inflammatory optic neuropathy; MOG antibody-associated disease; Multiple sclerosis; Neuro-ophthalmology; Neuromyelitis optica spectrum disorder; Optic neuritis.

MeSH terms

  • Aquaporin 4
  • Autoantibodies
  • Humans
  • Immunoglobulin G
  • Myelin-Oligodendrocyte Glycoprotein
  • Neuromyelitis Optica*
  • Optic Nerve Diseases*
  • Optic Neuritis* / diagnosis
  • Optic Neuritis* / etiology
  • Optic Neuritis* / therapy
  • Papilledema*
  • Vision Disorders

Substances

  • Myelin-Oligodendrocyte Glycoprotein
  • Autoantibodies
  • Aquaporin 4
  • Immunoglobulin G